Hydrogen bonding and proton transfer control the identity and reactivity of molecules in highly concentrated and alkaline aluminate solutions.

Gosline works to develop computational algorithms that are uniquely targeted for rare disease work by doing foundational research in model system development. This work can be expanded to all model systems in human disease.

A new method to convert waste plastic to fuel and raw materials promises to help close the carbon cycle at mild temperature and with high yield.

Data-driven autonomous technology to rapidly design and deliver antiviral interventions targeting SARS-CoV-2 to reduce drug discovery timeline and advance bio preparedness capabilities.

Exploring why some brains are more resilient to the impact of Alzheimer’s disease could lead to improved diagnoses, treatment and prevention.

A team from the Environmental Molecular Sciences Laboratory published research, demonstrating that the soil microbes were directly involved in the stabilization of soil organic carbon and mineral weathering.

Advanced proteomic analysis tools dig deep into human blood plasma to understand the molecular nature of advanced alcoholic disease.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

AAAS Fellows are a distinguished cadre of scientists, engineers, and innovators who have been recognized for their achievements across disciplines.

A paper by PNNL researchers has been chosen as one of 32 NIEHS Papers of the Year—a top 1% honor in the research field.

Four PNNL researchers specializing in nuclear waste management received awards from the ASTM International Committee C26 on Nuclear Fuel Cycle.

Microbes that were previously frozen in soils are becoming more active. This study demonstrates the diverse RNA viral communities found in thawed permafrost.

PNNL will partner with Commonwealth Fusion Systems to develop innovative steel materials for fusion applications under the INFUSE program

Tungsten heavy alloys show promise for nuclear fusion energy development, according to new research conducted at PNNL.

PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.

A new approach broadens the reach of quantum computers to previously challenging systems.

Findings show method to better prepare human lung tissue for study; it represents the latest mass spectrometry-based omics advances.

PNNL’s contributions over the last year span scientific discovery, sustainable energy and national security.

Clarivate recently released the list of Highly Cited Researchers for 2022.

The Joint Appointment program at PNNL is one of the most diverse among other U.S. national laboratories, involving nearly 60 universities and research institutions in the United States and abroad.